Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | G6PD | P11413 | 2/20 | 0.68 |
| ▸ | BCHE | P06276 | 9/20 | 0.65 |
| ▸ | ACHE | P22303 | 9/20 | 0.65 |
| ▸ | CNR2 | P34972 | 3/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | CA12 | O43570 | 1/20 | 0.45 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.45 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.45 |
| ▸ | ATM | Q13315 | 1/20 | 0.45 |
| ▸ | CA9 | Q16790 | 1/20 | 0.45 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.45 |
| ▸ | MEN1 | O00255 | 1/20 | 0.45 |
| ▸ | MAPT | P10636 | 1/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.45 |
| ▸ | MCHR1 | Q99705 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8945368 | 0.95 | G6PD (0.70) | G6PDBCHEACHECNR2ALDH1A1 | |
| SCHEMBL11790970 | 0.91 | BCHE (0.73) | G6PDBCHEACHECNR2ALDH1A1 | |
| SCHEMBL20595267 | 0.85 | G6PD (0.92) | G6PDBCHEACHEALDH1A1CA12 | |
| SCHEMBL11705721 | 0.84 | CA2 (0.53) | G6PDBCHEACHEALDH1A1CA12 | |
| SCHEMBL11025388 | 0.84 | G6PD (0.89) | G6PDBCHEACHEALDH1A1CA12 | |
| SCHEMBL13344367 | 0.84 | G6PD (0.89) | G6PDBCHEACHEALDH1A1CA12 | |
| SCHEMBL14024173 | 0.82 | G6PD (1.00) | G6PDBCHEACHEALDH1A1CA12 | |
| SCHEMBL17378580 | 0.81 | G6PD (0.57) | G6PDBCHEACHEALDH1A1CA12 | |
| SCHEMBL11607679 | 0.79 | BCHE (1.00) | G6PDBCHEACHEALDH1A1CA12 | |
| SCHEMBL10330805 | 0.79 | G6PD (0.79) | G6PDBCHEACHEALDH1A1CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0729465-B1 | PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS | PARKE DAVIS & CO (US) | 2003-01-22 | — | — | EP | disclosed |
| US-6005103-A | TREATMENT OF BACTERIAL AND VIRAL INFECTIONS AND DISEASES, INCLUDING AIDS | WARNER-LAMBERT COMPANY (US) | 1999-12-21 | — | — | US | disclosed |
| US-5808062-A | AIDS THERAPY | WARNER-LAMBERT COMPANY (US) | 1998-09-15 | — | — | US | disclosed |
| EP-0729465-A1 | PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS | PARKE, DAVIS & COMPANY (US) | 1996-09-04 | — | — | EP | disclosed |
| WO-1995014013-A1 | PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS | PARKE, DAVIS & COMPANY (US) | 1995-05-26 | — | — | WO | disclosed |